While the commencement of the U.S.’s COVID-19 vaccination campaign has brought a much-needed positive news cycle, the realization that supply will be limited for many months is...
The news that the Pfizer-BioNTech and Moderna vaccines are 95 percent effective at preventing COVID-19 disease, and the AstraZeneca-Oxford vaccine might be 90 percent effective (with...
Pfizer CEO Albert Bourla’s recent open letter on the potential timing of his company’s COVID-19 vaccine candidate provides clarity where earlier unscripted comments sowed...